Global Cardiovascular Partnering Report 2010-2017: Deal Trends, Players and Financials - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Cardiovascular Partnering 2010-2017: Deal trends, players and financials" report to their offering.

Global Cardiovascular Partnering 2010 to 2017 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.

The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

Global Cardiovascular Partnering 2010-2017: Deal trends, players and financials includes:

  • Trends in cardiovascular dealmaking in the biopharma industry since 2010
  • Analysis of cardiovascular deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to over 1,000 cardiovascular deal records
  • The leading cardiovascular deals by value since 2010

In Global Cardiovascular Partnering 2010-2017: Deal trends, players and financials, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Key Topics Covered:

Executive Summary

1. Introduction

2. Trends in Cardiovascular dealmaking

3. Financial deal terms for Cardiovascular partnering

4. Leading Cardiovascular deals and dealmakers

5. Cardiovascular contract document directory

6. Cardiovascular dealmaking by therapeutic target

For more information about this report visit http://www.researchandmarkets.com/research/cvlfw5/global

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Drugs